ClinicalTrials.gg
CompletedNCT06820242HIPS PilotUpdated Oct 7, 2026

Open Pilot Trial of a Mind-Body Intervention for Patients With Chronic Hip Pain

An interventional study of HIPS in Hip Pain, Hip Pain Chronic and Mind-Body Therapies, sponsored by Massachusetts General Hospital. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Other

How we know

Updated Oct 7, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
6
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Chronic Pain by Massachusetts General Hospital — 7 open to participants now, 8 under way, none of them phase 3. Chronic Pain · Massachusetts General Hospital.

Enrollment
22nd of 23
6 · median 60
Started
2025
with 2 others
No phase
20 of 27
5 open now
Registered
22nd of 27
by date

Among the 27 studies in Chronic Pain by Massachusetts General Hospital, this one is the 22nd largest by enrollment of the 23 interventional ones that give a count, is one of 3 that started in 2025, is one of 20 with no phase, and was the 22nd registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

7 of the 27 studies in Chronic Pain by Massachusetts General Hospital are open now, in 1 country. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Chronic Pain by Massachusetts General Hospital, or all of them as a file.
02

Study summary

The goal of this study is to conduct a feasibility open pilot study (N=5) of HIPS with virtual exit interviews among adult patients with chronic hip joint-related pain (HRP). We will use this mixed methods information to assess the feasibility, credibility, and acceptability of the HIPS intervention and optimize the program and study methodology in preparation for a pilot feasibility randomized control trial (RCT).

Deliverables: [1] Adapt and refine open pilot protocol, patient recruitment, provider training, and other study materials. [2] Assess the feasibility, acceptability, and credibility of HIPS in preparation for a future feasibility RCT.

Read the detailed description

Aim: Conduct a feasibility open pilot study (N=5) of HIPS with virtual exit interviews among adult patients with chronic HRP. The ultimate goal of this research is to assess the feasibility, credibility, and acceptability of the HIPS intervention and optimize the program and study methodology in preparation for a pilot feasibility randomized control trial (RCT).

HIPS Intervention: HIPS is a 6-session (one 30-minute session per week) mind-body intervention delivered virtually via live-video by a trained physical therapist (PT). In addition to participating in the HIPS intervention, all participants will attend their prescribed physical therapy with a physical therapist of their choosing. To minimize variability in physical rehabilitation, we will send the physical therapist the Clinical Practice Guidelines, which outline a standard-of-care rehabilitation protocol. Across the six 30-minute sessions, the HIPS intervention aims to teach relaxation and coping skills (e.g., SMART goal-setting, coping thoughts, deep breathing, and progressive muscle relaxation) and provides pain education. After each session, the participant is instructed to set and meet a physical activity SMART goal for the coming week. Within the program manual will be a log where the participant may track their completion of home practice. Each week, participants will receive a survey to formally report their daily home practice data over the last 7 days.

Following program completion, there will be a one-time 30-minute virtual exit interview to elicit subject perceptions of HIPS and any recommendations to improve intervention quality. This information will be used to further adapt and optimize HIPS prior to future efficacy testing.

Assessments: Baseline (0 weeks), post-test (6 weeks), and 6-month follow-up (30 weeks) survey assessments.

03

Conditions studied

  • Hip Pain
  • Hip Pain Chronic
  • Mind-Body Therapies

Keywords

  • chronic hip pain
  • mind-body
  • mindfulness
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Presenting with chronic (lasting ≥3 months) hip joint-related pain (HRP)
  2. Age ≥18yr

    a. If ≥45yr, the physician will confirm no osteoarthritis via X-ray (Kellgren Lawrence [KL] grade 0-1)

  3. Score ≥3 for current hip pain on the Pain Visual Analogue Scale (Pain VAS)
  4. Exhibits poor psychosocial health by meeting ≥1 of the criteria listed below:

    1. Score ≥ 20 on the Pain Catastrophizing Scale (PCS)
    2. Score ≤ 40 on the Pain Self-Efficacy Questionnaire (PSEQ)
    3. Score ≥ 17 on the Tampa Scale for Kinesiophobia (TSK-11)
  5. Exhibits sedentariness by meeting ≥1 of the criteria listed below:

    1. Physically active \< 150mins/week according to the International Physical Activity Questionnaire (IPAQ)
    2. Hip pain interferes with ability to be physically active
    3. Dissatisfaction with current physical activity level

Exclusion criteria

Exclusion Criteria:

  1. Previous surgery on the symptomatic (painful) hip
  2. Current pain referred from the lower back
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
6 participants (actual)

Study arms

  • Experimental
    HIPS

    A 6-session mind-body intervention that teaches patients with chronic hip joint-related pain (HRP) coping skills (e.g., SMART goal-setting, coping thoughts, deep breathing, and progressive muscle relaxation) and pain education.

    Behavioral: HIPS

Interventions

  • BehavioralHIPS

    HIPS is a 6-session (one 30-minute session per week) mind-body intervention delivered virtually via live video by a trained physical therapist (PT). Across these six 30-minute sessions, the HIPS intervention aims to teach relaxation and coping skills (e.g., SMART goal-setting, coping thoughts, deep breathing, and progressive muscle relaxation) and provides pain education.

06

What researchers measure

Primary outcomes

  1. Proportion of Participants Who Scored Above the Midpoint on Each Subscale of the Credibility and Expectancy Questionnaire

    Assessed using the Credibility and Expectancy Questionnaire which asks the participant to indicate how much they believe, right now, that the intervention they will receive will help manage their COP and related worry. Possible scores range from 3 to 27 for both the credibility and the expectancy subscales. Higher scores represent higher credibility and expectancy.

    Time frame: Baseline (0 Weeks)

  2. Proportion of Participants Who Scored Above the Midpoint on the Client Satisfaction Scale

    Measured using the Client Satisfaction Scale which assess participants' satisfaction with participation in the study. The score range is 0-12. Higher scores indicate greater satisfaction.

    Time frame: Post-Test (6 Weeks)

  3. Feasibility of recruitment

    The percent of eligible patients approached that agree to participate.

    Time frame: Baseline (0 Weeks)

  4. Rate at which program was accepted, measured by number of completed program sessions

    The proportion of participants who attend ≥4 of 6 sessions.

    Time frame: Post-Test (6 Weeks)

  5. Feasibility of Assessments at Baseline

    Rate of participant's completion of self-report measures, with no measures missing.

    Time frame: Baseline (0 Weeks)

  6. Feasibility of Assessments at Post-Test

    Rate of participant's completion of self-report measures, with no measures missing.

    Time frame: Post-Test (6 Weeks)

  7. Feasibility of Assessments at Follow-Up

    Rate of participant's completion of self-report measures, with no measures missing.

    Time frame: Follow-Up (30 Weeks)

  8. Adverse Events

    Any self-reported or observed negative events related to participation

    Time frame: Collected during intervention, an average of 6 weeks

  9. Therapist adherence

    Rate of interventionist's delivering the programs by following the established session topics and practices

    Time frame: Collected during intervention, an average of 6 weeks

  10. Proportion of participants who report symptom improvements as measured by the Global Rating of Change Scale

    The proportion of participants who report overall improvement on the Global Rating of Change Scale. This measure includes a single question asking the patient to rate their change with respect to their hip condition over the last 6 weeks. Higher scores indicate better outcomes.

    Time frame: Post-Test (6 Weeks)

Secondary outcomes

  1. Pain Visual Analogue Scale (Pain-VAS)

    A single-item scale measuring self-reported pain intensity. Scores on the Pain-VAS range from 0 (no pain) to 100 (worst pain imaginable) and higher scores equate to worse outcomes.

    Time frame: Baseline (0 Weeks), Post-Test (6 Weeks), Follow-Up (30 Weeks)

  2. International Hip Outcome Tool (iHOT-12)

    A 12-item questionnaire to assess deficiencies with respect to outcome assessment for young, active patients with hip disorders. Total scores range from 0 to 100 and higher scores represent better quality of life

    Time frame: Baseline (0 Weeks), Post-Test (6 Weeks), Follow-Up (30 Weeks)

  3. PROMIS Pain Interference - Short Form 6b

    A 6-item measure assessing self-reported consequences of pain on relevant aspects of a person's life and including the extent to which pain hinders engagement with social, cognitive, emotional, physical, and recreational activities. Scores range from 6 to 30 where higher scores equate to worse outcomes.

    Time frame: Baseline (0 Weeks), Post-Test (6 Weeks), Follow-Up (30 Weeks)

  4. Multidimensional Assessment of Interoceptive Awareness (MAIA)

    A 32-item state-trait questionnaire to measure multiple dimensions of interception. Scores on item range from 0 to 5 and higher scores translate to better outcomes.

    Time frame: Baseline (0 Weeks), Post-Test (6 Weeks), Follow-Up (30 Weeks)

  5. International Physical Activity Questionnaire (IPAQ)

    A 27-item self-reported measure assessing physical activity. Overall score on the IPAQ is calculated using responses to all questions. More physical activity translates to better outcomes.

    Time frame: Baseline (0 Weeks), Post-Test (6 Weeks), Follow-Up (30 Weeks)

  6. Pain Catastrophizing Scale (PCS)

    A 13-item questionnaire assessing one's tendency to focus on pain-related thoughts and feel helpless and hopeless due to pain on a scale of 0 to 4. Total scores range from 0 to 25 and higher scores indicate higher pain catastrophizing (worse outcomes).

    Time frame: Baseline (0 Weeks), Post-Test (6 Weeks), Follow-Up (30 Weeks)

  7. Tampa Kinesiophobia Scale (TSK)

    An 11-item questionnaire that assesses fear avoidance and fear of activity. Summary score of total responses with Minimum = 11 and Maximum = 44. Higher scores indicate higher kinesiophobia.

    Time frame: Baseline (0 Weeks), Post-Test (6 Weeks), Follow-Up (30 Weeks)

  8. Pain Self-Efficacy Questionnaire (PSEQ)

    A 10-item measure assessing the confidence people with ongoing pain have in performing activities while in pain. Each item is scored on a 7-point Likert scale where 0 (not at all confident) and 6 (completely confident). Total scores range from 0 to 60 and higher scores translate to better outcomes.

    Time frame: Baseline (0 Weeks), Post-Test (6 Weeks), Follow-Up (30 Weeks)

  9. Whole Person Health Index (WPHI)

    A 9-item measure assessing self-reported overall well-being. Each item is rated on a 1-5-point scale (total scores ranging from 9 to 45), with higher scores indicating worse overall well-being.

    Time frame: Baseline (0 Weeks), Post-Test (6 Weeks), Follow-Up (30 Weeks)

  10. Change in Step Count via the ActiGraph wGT3X-BTLE Accelerometer

    Measures the change in steps during the 7 days following the baseline assessment and 7 days preceding the post-test. Larger increase in activity translate to better outcomes.

    Time frame: Baseline (0 Weeks), Post-Test (6 Weeks)

07

Study locations

1 site
  • Massachusetts General Hospital
    Boston, Massachusetts 02114, United States
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2025 to primary completion in Apr 2026, 12 months.

Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's 12 months is below that.

Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.

Completion moved once since we started tracking on Sep 25, 2026: Sep 2026 → Oct 2026, on Oct 7, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 6, 2025
First posted
Feb 11, 2025
StartActual
Apr 4, 2025
Primary completionActual
Apr 15, 2026
CompletionActual
Oct 5, 2026was Sep 2026
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Oct 7, 2026
Primary completion
Apr 30, 2026→Apr 15, 2026 (actual)
Oct 7, 2026
Study completion
Sep 2026→Oct 5, 2026 (actual)
Oct 7, 2026
Enrollment
5 (estimated)→6 (actual)
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Active, not recruiting→Completed
    Primary completion Apr 30, 2026→Apr 15, 2026 (now actual)
    Study completion Sep 2026→Oct 5, 2026 (now actual)
    Enrollment 5 (estimated)→6 (actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06820242
Responsible party
Kate Jochimsen (Principal Investigator, Massachusetts General Hospital) — Principal investigator
First posted
Feb 11, 2025
Start date
Apr 4, 2025
Primary completion
Apr 15, 2026
Completion
Oct 5, 2026
Last update
Oct 7, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion